6 enregistrements totalisant 8,347,914.00 $ CAN, selon les données ouvertes officielles du gouvernement du Canada.
| Instituts de recherche en santé du Canada | $8,347,914 | 6 enregistrements |
Development of a safe, effective and clinically acceptable VSV-based HIV vaccine
Development of an animal model, a protective vaccine and monoclonal antibodies against Crimean-Congo Hemorrhagic Fever Virus
Canada Research Chair Tier 1
The specific objectives of the Canadian 2019-nCoVrapid research funding opportunity are to: • Contribute to the global response to the 2019-nCoV outbreak; • Enhance local, national and/or internat...
A DNA-Based Universal Seasonal Influenza Vaccine Phase I Safety and Immunogenicity Study
Determinants of virulence and transmission in the West African Ebola outbreak